Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol and ECPR strategies for in-hospital cardiac arrest
ChiCTR2300068437Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esmolol in cardiac arrest (SCA) (4 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: 20-minute return of spontaneous circulation. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
esmolol
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on ChiCTR2300068437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068437.